Prognostic utility of HPV specific testing in addition to p16 immunohistochemistry in oropharyngeal squamous cell carcinoma

被引：9
|
作者：
Sathasivam, H. P. [1 ]
Santambrogio, A. [2 ]
Andoniadou, C. L. [2 ]
Robinson, M. [1 ]
Thavaraj, S. [3 ]
机构：
[1] Newcastle Univ, Ctr Oral Hlth Res, Newcastle Upon Tyne, Tyne & Wear, England
[2] Kings Coll London, Ctr Craniofacial & Regenerat Biol, London, England
[3] Kings Coll London, Mucosal & Salivary Biol, London, England
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷 / 10期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1093/annonc/mdy313
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2144 / 2145
页数：2
相关论文
共 50 条
  • [1] Utility of p16 and HPV in Oropharyngeal Squamous Cell Carcinoma: An Institutional Review
    Huenerberg, Katherine
    Colletti, Shanna
    Nassar, Aziza
    [J]. MODERN PATHOLOGY, 2019, 32
  • [2] Utility of p16 and HPV in Oropharyngeal Squamous Cell Carcinoma: An Institutional Review
    Huenerberg, Katherine
    Colletti, Shanna
    Nassar, Aziza
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [3] HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study
    Lilja-Fischer, Jacob Kinggaard
    Kristensen, Morten Horsholt
    Lassen, Pernille
    Steiniche, Torben
    Tramm, Trine
    Stougaard, Magnus
    Maare, Christian
    Johansen, Jorgen
    Primdahl, Hanne
    Kristensen, Claus Andrup
    Andersen, Maria
    Eriksen, Jesper Grau
    Overgaard, Jens
    [J]. ACTA ONCOLOGICA, 2023, 62 (11) : 1384 - 1388
  • [4] Is there justification for age bias in HPV p16 testing for Oropharyngeal Squamous Cell Carcinoma?
    McCauley, S.
    McCloskey, P.
    Lyons, C.
    Brown, K.
    Rooney, K.
    Houghton, F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 50 - 51
  • [5] Cell Block p16 Immunohistochemistry in Metastatic Oropharyngeal Squamous Cell Carcinoma
    Jalaly, J. B.
    Bernadt, C.
    Lewis, J.
    [J]. MODERN PATHOLOGY, 2014, 27 : 106A - 106A
  • [6] Cell Block p16 Immunohistochemistry in Metastatic Oropharyngeal Squamous Cell Carcinoma
    Jalaly, J. B.
    Bernadt, C.
    Lewis, J.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 106A - 106A
  • [7] Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status
    Benzerdjeb, Nazim
    Tantot, Juliet
    Blanchet, Christophe
    Philouze, Pierre
    Mekki, Yahia
    Lopez, Jonathan
    Devouassoux-Shisheboran, Mojgan
    [J]. HISTOPATHOLOGY, 2021, 79 (03) : 381 - 390
  • [8] The Prognostic Significance of the Biomarker p16 in Oropharyngeal Squamous Cell Carcinoma
    Oguejiofor, K. K.
    Hall, J. S.
    Mani, N.
    Douglas, C.
    Slevin, N. J.
    Homer, J.
    Hall, G.
    West, C. M. L.
    [J]. CLINICAL ONCOLOGY, 2013, 25 (11) : 630 - 638
  • [9] Utility of p16 andHPVtesting in oropharyngeal squamous cell carcinoma: An institutional review
    Abdelhakam, Dina A.
    Huenerberg, Katherine A.
    Nassar, Aziza
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (01) : 54 - 59
  • [10] Human papillomavirus detection in oropharyngeal squamous cell carcinoma using p16 immunohistochemistry
    Sabu, Annetmary
    Mouli, N. V. Ratna
    Tejaswini, N.
    Rohit, V.
    Nishitha, G.
    Uppala, Divya
    [J]. INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2019, 9 (04) : 212 - 216
12345